维普期刊资源整合服务平台（V6.5）

80篇 您的检索式：作者名="Mayer LD"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	P-glycop rotein modulates ceramide-medi- atedsensitivity of human breast cancer cells to tubulin-binding anti- cancer drugs显示文摘	Shabbits JA Mayer LD	2002	Mol Cancer Ther2002，1，3：	1
2	Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient显示文摘	MAYER LD CULLIS PR BALLY MB	1986	Biochim Biophys Acta1986，857，：	1
3	Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumer wfficacy of doxorubicin 显示文摘	Balazsovits JAE Mayer LD Bally MD	1989	Cancer Chemother Pharmacol1989，23，：	1
4	Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubiein and empty liposomes in mice and dogs显示文摘	KANTER PM BULLARD GA PILIEWICZ FG MAYER LD	1993	In Vivo1993，1，：	1
5	Tumor chemosensitizationstrategies based on apoptosis manipulations显示文摘	Shabbits JA Hu HP Mayer LD	2003	Mol CancerTher2003，2，8：	1
6	P-glycoprotein modulates ceramide mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs显示文摘	Shabbits JA Mayer LD	2002	Mol Cancer Ther2002，1，3：	1
7	Optimization of the retention properties of vincristine in liposomal systems 显示文摘	Boman NL Mayer LD Cullis PR	1993	Biochimica Biophysica Acta1993，1152，：	1
8	P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs显示文摘	Mayer LD	2002	Mol Cancer Ther2002，1，：	1
9	Mechanisms,reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs 显示文摘	Krishna R Mayer LD	2000	Eur JP harm Sci2000，11，4：	1
10	Pulsed exposure of SDZ PSC833 to multidrug resistant P388/ADR and MCFT/ADR cells in the absence of anticancer drugs can fully restore sensitivity to doxorubicin 显示文摘	Krishna R de Jong G Mayer LD	1997	Anticancer Res1997，17，：	1
11	P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs显示文摘	Shabbits JA Mayer LD	2002	Mol Cancer Ther2002，1，3：	1
12	Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin显示文摘	Lopes de Menezes DE Hudon N McIntosh N Mayer LD	2000	Clin Cancer Res2000，6，7：	1
13	Multidrug resistanee(mdr)in cancer mechanisms, reversal using modulators of mdr and the role of mdr in influencing the pharmacokineties of anticancer drugs 显示文摘	Krishna R Mayer LD	2000	EurJ Pharm Sci2000，11，4：	1
14	Pulsed exposure of SDZ PSC 833 to multidrug resistant P388/ADR and MCF7/ADR cells in the absence of anticancer drugs can fully restore sensitivity to doxorubicin显示文摘	Krishna R De Jong G Mayer LD	1997	Anticancer Res1997，17，5：	1
15	P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs显示文摘	Shabbits JA Mayer LD	2002	Mol Cancer Ther2002，1，：	1
16	Intravenous pretreatment with empty pH gradient liposomes alters the pharmacokinetics and toxicity of doxorubicin through in vivo active drug encapsulation显示文摘	Mayer LD Reamer J Bally MB	1999	J Pharm Sci1999，88，1：	1
17	P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs显示文摘	Shabbits JA Mayer LD	2002	Mol Cancer Ther2002，1，3：	1
18	Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients显示文摘	Tai LCL Bally MB	1990	Biochim Biophys Acta1990，1025，2：	1
19	P-glycoprotein modulates ceramidemediated sensitivity of human breast cancer cells to tubulinbinding anticancer drugs显示文摘	Shabbits JA Mayer LD	2002	Mol Cancer Ther2002，1，：	1
20	Influence of vesiclesize,lipid composition,and drug-to-hpid ratio on the biologicalactivity of liposomal doxorubicin in mice显示文摘	MAYER LD TAILC L KODS C	1989	Cancer Res1989，49，21：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示